Positive Results from RhoVac's Clinical Phase I/II Study published in Journal of ImmunoTherapy of Cancer
RhoVac announces today, November 13, 2020, that the results of its clinical phase I/II study have been published in the Journal for ImmunoTherapy of Cancer (JITC). The scientifically reviewed article reports that the treatment with RhoVac’s drug candidate RV001 was safe and well tolerated, and that a long-lasting immune response could be generated in the vast majority of patients. In the patients who had a measurable PSA when they started the study, a markedly increased PSA doubling time was seen, indicating cancer-specific effectiveness.The Phase I / II clinical study included 22 patients
Kiilto är ett familjeägt företag från Finland etablerat 1919 med en uttalad vision fram till 2080. Vi utvecklar, tillverkar och marknadsför kemiska produkter och tjänster inom fyra affärsområden: bygg, industriell limning, professionell hygien och konsumentverksamhet. De viktigaste principerna för vår verksamhet är miljöledarskap, närhet och engagemang för framtiden. Vi verkar i 11 länder och har cirka 1 000 anställda. I vårt Promise to the environment ingår målet att vara koldioxidneutrala 2028.
Nu i november fusionerades TM Progress med Kiilto för att kunna erbjuda kunderna en
XMReality AB (publ) has received an order from IMI division Hydronic Engineering for XMReality Remote Guidance and supporting hardware. In April 2020 XMReality signed the first contract with IMI where the intended use area was through their division Critical Engineering, this is now an additional order for more licenses and hardware for their division Hydronic Engineering.IMI Hydronic Engineering is a leading supplier of products for hydronic distribution systems such as energy efficient heating and cooling systems to the residential and commercial building sectors. They plan to deploy
Press release 44/2020, WOW Symposium on 13th November 2020, Espoo FinlandEmbargoed until 13.11.2020 10 am (9 am CET)
New studies from a large NordForsk consortium confirm that night shift work is associated with increased risk for serious health risks like accidental injuries and sickness absence. The researchers give recommendations on how to organize shift work in order to minimise health and safety risks.About 20% of all employees in Europe are shift workers. A large NordForsk-funded project (Working Hours, Health, Well-being and Participation in Working Life, WOW) produced several
Press release 43/2020, WOW Symposium on 13[th] November 2020, Espoo, FinlandEmbargoed until 13.11.2020 10 am (9 am CET)
Good work-time control improves work-life balance and allows employees to self-determine the timing of, e.g., the start and ending times of the workday, and timing of vacations and breaks. New Nordic studies indicate that good work-time control protects against the risk for musculoskeletal and mental symptoms, sickness absence and occupational accidents.Flexible working hours have increased dramatically recently, also due to the COVID-19 pandemic. Flexible working
